Recommendations on transfusion therapy in Neonatology;Raccomandazioni per la terapia trasfusionale in neonatologia

Blood Transfusion

Volumn 4, Issue 2, 2006, Pages 158-180

  Tripodi, G ^a   Antoncecchi, S ^a   Fanetti, G ^a   Girelli, G ^a   Isernia, P ^a   Marini, M ^a   Perugini, L ^a   Pupella, S ^a   Reali, G ^a   Salvaneschi, L ^a   Tiburzi, A ^a   Bonomo, P ^a   Motta, M ^a   Casadei, A M ^a   Casani, A ^a   Chirico, G ^a   D'Ajello, L ^a   Delvecchio, A ^a   Frusca, T ^a   Muratori, C ^a   Perrone, S ^a   Pinto, L ^a   Radiconi, M ^a   Rugolotto, R ^a   Santilli, T ^a   Testa, M ^a   Anzoni, R ^a   Buonocore, G ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ANTIGEN; THROMBOCYTE CONCENTRATE;

ANEMIA; BLEEDING; BLOOD TRANSFUSION; CROSS REACTION; CYTOMEGALOVIRUS INFECTION; ERYTHROCYTE; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; IMMUNE DEFICIENCY; INTRAUTERINE BLOOD TRANSFUSION; NEWBORN; PROPHYLAXIS; REVIEW; THROMBOCYTOPENIA; TREATMENT INDICATION; VERY LOW BIRTH WEIGHT;

EID: 47749118749     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Decreto 3 Marzo 2005: Caratteristiche e modalità per la donazione di sangue e di emocomponenti. GU 13/04/2005 N. 85.
2. Decreto 3 marzo 2005: Protocolli per l'accertamento della idoneità del donatore di sangue e di emocomponenti. GU. 13/04/2005 N. 85.
3. Decreto 19 agosto 2005, n.191: Attuazione della direttiva 2002/98/CE che stabilisce norme di qualità e di sicurezza per la raccolta, il controllo, la lavorazione, la conservazione e la distribuzione del sangue umano e dei suoi componenti. GU 22/09/2005 N. 221.
4. Legge 21 ottobre 2005, n.219: Nuova disciplina delle attività transfusionali e della produzione nazionale degli emoderivati. GU 27/10/2005 N. 251.
5. British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines on the clinical use of leucocyte-depleted blood components. Transfusion Med 1998; 8: 59-71.
6. th edition. 2004. Council of Europe Publishing, Strasbourg.
7. Strauss RG. Transfusion approach to neonatal anemia. Neo Reviews 2000; l:74-80.
8. British Committee for Standards in Haematology. Transfusion guidelines for neonates and older children. Br J Haematol 2004;124: 433-53.
9. Preiksaitis JK, Brown L, McKenzie M. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study. Transfusion 1988; 28: 205-9.
10. Ronghe MD, Foot AB, Cornish JM, et al. The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. Br J Haematol 2002;118: 124-7.
11. Mussi-Pinhata MM, Pinto PC, Yamamoto AY, et al. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. J Med Virol 2003; 69: 232-9.
12. th Edition. 2002. AABB, Bethesda.
13. Preiksaitis JK. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? Transfus Med Rev 2000; 14: 112-36.
14. Laupacis A, Brown J, Costello B et al. Prevention of post-transfusion CMV in the era of universal leukoreduction: a consensus statement. Transfusion 2001; 41: 560-96.
15. International Forum. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?Vox Sang 2002; 83: 72-8.
16. th Edition. 2001. AABB, Bethesda.
17. British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines on gamma-irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfusion Med 1996; 6: 261-71.
18. Roseff SD, Luban NLC, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002; 42: 1398-413.
19. British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Med 1996; 6: 273-83.
20. Floss AM, Strauss RG, Goeken N, Knox L. Multiple transfusions fail to provoke antibodies against blood cell antigens in human infants. Transfusion 1986; 26: 419-22.
21. Ludvigsen CW Jr, Swanson JL, Thompson TR, McCullough J. The failure of neonates to form red blood cell alloantibodies in response to multiple transfusions. Am J Clin Pathol 1987; 87: 250-1.
22. Strauss RG, Johnson K, Cress G, Cordle DG. Alloimmunization in preterm infants after repeated transfusions of WBC-reduced RBCs from the same donor. Transfusion 2000; 40: 1463-8.
23. Rodeck CH, Deans A. Red cell allo-immunisation. In: Fetal Medicine: Basic Science and Clinical Practice. Rodeck CH, Whittle MJ (editors). Churchill Livingstone, New York, 1999. p. 785-804.
24. Strauss RG. Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin. Transfus Med Rev 2006; 20: 34-44.
25. Ross MP, Christensen RD, Rothstein G et al. A randomised trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol 1989; 9: 246-53.
26. Pupella S, Girelli G, Casadei AM, et al. Protocollo operativo per la terapia trasfusionale del neonato: risultati preliminari. La Trasf del Sangue 1999; 44: 298-303.
27. Miyashiro AM, dos Santos N, Guinsburg R, et al. Strict red blood cell transfusion guideline reduces the need for transfusions in very-low-birthweight infants in the first 4 weeks of life: a multicentre trial. Vox Sang 2005; 88: 107-13.
28. Andersen C. Critical haemoglobin thresholds in premature infants. Arch Dis Fetal Neonatal Ed 2001; 84: F146-8.
29. Wardle SP, Crawley E, Yoxall CW et al. Peripheral oxygenation and anaemia in preterm babies. Pediatr Res 1998; 44:125-31.
30. Shannon KM, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95: 1-8.
31. Murray N A, Roberts IAG. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004; 89: F101-7.
32. Maier RF, Obladen M, Kattner E, et al. High- versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 1998; 132: 866-70.
33. th ed. Rudolph A (editor). New York, Appleton-Century-Crofts, 1977, p.1111.
34. Northern Neonatal Nursing Initiative Trial Group. Randomised trial of prophylactic early fresh frozen plasma, gelatin or glucose in pre-term babies: outcome at 2 years. Lancet 1996; 348: 229-32.
35. Andrew ME, Monagle P, de Veber G, Chan AKC. Thromboembolic disease and antithrombotic therapy in newborns [review]. (ASH) Hematology 2001;358-74.
36. British Committee for Standards in Haematology. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002; 119: 295-309.
37. Levi M, Ten Cate H. Disseminated intravascular coagulation [review]. N Engl J Med 1999; 341: 586-92.
38. Stanworth SI, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective?Asystematic review of randomised controlled trials. Br J Haematol 2004; 126: 139-52.
39. Santagostino E, Mancuso M E, Morfini M, et al. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica 2006; 91: 634-9.
40. Andrew M, Castle V, Saigal S, et al. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987; 110: 457-64.
41. Andrew M, Vegh P, Caco C, et al. Randomised controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123; 285-91.
42. Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions. Transfusion 2001; 41: 803-8.
43. Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003;88: F359-64.
44. Cairo MS. Immunotherapy in the prophylaxis and treatment of neonatal sepsis. Curr Opin Pediatr 2003; 15: 155-60.
45. Mohan P, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia [review]. Cochrane Database Syst Rev 2003; (4): CD003956.
46. So KW, Fok TF, Ng PC, Wong WW, Cheung KL. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 76: F43-6.
47. Cochrane Injuries Group Albumin Reviewers. Human Albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 1998; 317: 235-40.
48. Duguid JK, Minards J, Bolton-Maggs PH. Lesson of the week: incompatible plasma transfusions and haemolysis in children. Br Med J 1999; 318: 176-7.
49. Eder AF, Manno CS. Does red cell T activation matter? Br J Haematol 2001; 114: 25-30.
50. Ramasethu J, Luban NLC. T activation. Br J Haematol 2001; 112: 259-63.
51. Hambleton J, Leung LL, Levi L. Coagulation: consultative hemostasis. (ASH) Hematology 2002; 335-52.
52. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72.